Clinical trial
(Bispecific) Antibodies in Cancer Patients (InHeAb01)
NCT05119257 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- (Bispecific) Antibodies in Cancer Patients (InHeAb01)
- Lead sponsor
- University Hospital Tuebingen
- Phase
- Expanded access
- Overall status
- Available
- Start date
- Not reported
- Completion date
- Not reported
- Enrollment
- Not reported
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cancer